Lotus Pharmaceutical Co. Ltd Financials

Market Capitalization TW$68.38 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	15.66
Forward PE	10.99
Price to Sales TTM	TW$3.89
Price to Book MRQ	TW$3.34
Enterprise to Revenue	4.31
Enterprise to EBITDA	11.72

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	24.63%
Operating Margin	40.36%
Return on Assets TTM	9.48%
Return on Equity TTM	23.42%

Income Statement

Revenue TTM	TW$17,594,374,144
Revenue per Share TTM	TW$67.25
Quarterly Revenue Growth	14.50%
Gross Profit TTM	TW$9,920,937,984
EBITDA	TW$7,232,408,000
Net Income to Common TTM	TW$4,332,935,168
Diluted EPS TTM	TW$16.47
Quarterly Earnings Growth YoY	25.60%

Balance Sheet

Total Cash MRQ	TW$3,687,536,896
Total Cash per Share MRQ	TW$14.09
Total Debt MRQ	TW$
Total Debt to Equity MRQ	61.63
Current Ratio MRQ	2.54
Book Value per Share MRQ	TW$77.25

Cash Flow

Operating Cash Flow TTM	TW$4,621,943,808
Levered Free Cash Flow TTM	TW$2,278,256,128

1795 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	265,024,000
Float Shares	156,508,482
Avg 10 Volume	1,262,814
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	38.14%
% Held by Institutions	11.94%

Stock Price Summary

Beta	0.54
Fifty Two Week Low	TW$210.50
Fifty Two Week High	TW$347.00
Fifty Two Week Change	-7.36%
Day 50 MA	TW$272.30
Day 200 MA	TW$280.64

Dividends and Splits

Forward Annual Dividend Rate	TW$4.65
Forward Annual Dividend Yield	1.81%
Trailing Annual Dividend Rate	TW$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	28.22%
Dividend Date
Ex Dividend Date	2024-08-05
Last Split Factor
Last Split Date	2010-09-08